Skip to main content

Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double

Sales of popular weight loss drug Wegovy more than doubled to 9.38 billion kroner.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.